Our Largest and Most Strategic Markets
The Americas, led by the United States of America (USA) and Canada, represent Strides’ largest commercial region and a key pillar of our global growth strategy. With a robust presence across North America, we play a vital role in enhancing access to quality and affordable generic medicines.
In the US, the world’s largest pharmaceutical market, Strides has established a robust and expanding portfolio approved abbreviated new drug applications (ANDAs), supported by our front-end commercial operations and strong distribution partnerships. Our state-of-the-art facilities in the region ensure reliable supply and compliance with stringent regulatory standards, including those of the US FDA.
Canada complements our regional strategy as a marketing and distribution-led operation, leveraging both Strides-owned and partnered operations. With an expanding portfolio in key therapeutic categories such as antivirals, antibiotics, NSAIDs, and allergy treatments, we serve patients and partners in one of the world’s most regulated pharmaceutical markets.
Together, the US and Canada form a high-compliance, innovation-led market cluster where Strides continues to grow through a mix of partnership solutions and evolving customer solutions. North America is not just a revenue driver, it is a hub for product launches, regulatory excellence, and long-term brand presence.
The United States of America
A Strategic Hub for Manufacturing & Market Access
Strides Pharma Inc. serves as the US front-end business of Strides Pharma Science Limited and is a key driver of our global generics’ strategy. As both a manufacturing and distribution hub, our US operations reflect Strides’ commitment to delivering high-quality, affordable pharmaceutical products to one of the world’s most highly regulated markets.
With a specialized focus on oral solids, modified-release formulations, topicals, and liquids, we are well-positioned across diverse dosage forms. Our US portfolio includes a mix of high-competition products and over the counter (OTC) ANDAs, particularly in therapeutic segments such as NSAIDs, allergy relief, and osmotic laxatives.
Backed by a fully integrated value chain and a strong R&D engine, Strides Pharma, Inc. emphasizes speed-to-market, timely regulatory approvals, and sustained growth. Our business operates on a B2B model, with a strong emphasis on strategic partnerships, efficient commercialization, and compliance with US FDA regulations.
Our presence in the US not only gives us proximity to a large base of customers and patients but also reinforces our role in making proven, cost-effective treatments more accessible. As a wholly Strides-owned entity, our US operations are central to our mission of driving healthcare impact at scale.
Canada
Expanding Access through Smart Partnership and Market Reach
Strides Pharma’s presence in Canada reflects our growing commitment to serve regulated, high-potential markets with quality generic pharmaceuticals. Operating primarily as a marketing and distribution hub, Strides Canada plays a critical role in expanding patient access to affordable medicines across key therapeutic areas.
Our business model in Canada currently operates on a partnership solutions platform, complemented by plans to build a direct-to-market presence with its customer solutions platform to strengthen brand visibility and consumer engagement. Leveraging both Strides-owned operations and strategic partnerships, we offer a flexible, scalable approach tailored to meet local market dynamics.
Canada’s stringent regulatory landscape requires bioequivalence (BE) studies using local reference products, underscores our unwavering commitment to quality and compliance. Our growing portfolio in the region includes generics in categories such as antivirals, antibiotics, NSAIDs, allergy treatments, osmotic laxatives, and vitamin D analogs—addressing both chronic and acute care needs.
As an integral part of our broader North America strategy, Strides Canada complements our US operations and reinforces our mission to deliver value-driven healthcare solutions across the continent.
